Last reviewed · How we verify

NCT02819206

Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs

Completed NA Last updated 21 April 2023
What this trial tests

NA trial testing Blood sampling in Uveitis in 225 participants. Completed in 26 October 2022.

Timeline
7 June 2013
Primary endpoint
6 March 2019
26 October 2022

Quick facts

Lead sponsorAssistance Publique Hopitaux De Marseille
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment225
Start date7 June 2013
Primary completion6 March 2019
Estimated completion26 October 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Assistance Publique Hopitaux De Marseille — full company profile →

Who can join

18 and older, any sex, with Uveitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our research project is to use a new microbiological diagnostic strategy of uveitis, allowing detection of the fastidious pathogens of infectious Uveitis who are not diagnosed by laboratory methods used in diagnostic routine. This new diagnostic strategy is to automatically detect the presence of a pathogen fastidious in cell culture using the same patient's serum to reveal a positive culture, based on the assumption that this serum contains antibodies specific pathogen tedious. Finally, the main purpose of this study is to improve the etiological diagnosis of Uveitis by establishing a new diagnostic strategy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood sampling

Trials testing the same drug.

Other recruiting trials for Uveitis

Currently open trials in the same condition.

Other Assistance Publique Hopitaux De Marseille trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02819206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing